Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration

Clinical trial NCT01176903 · COMPLETED

Trial details

NCT number: NCT01176903
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2010-08-01
Primary completion: 2010-11-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.